The overall safety profile appeared similar between the agents, and the reduction in HbA 1c was greatest for exenatide
Dose reduction or discontinuation may be necessary if you develop: Persistent, intolerable gastrointestinal symptoms despite supportive measures Acute pancreatitis (discontinue permanently) Severe hypoglycemia, particularly if taking concurrent insulin or sulfonylureas Acute kidney injury or worsening renal function Gallbladder disease symptoms (abdominal pain, jaundice) Diabetic retinopathy complications (particularly with semaglutide) Severe hypersensitivity reactions including anaphylaxis or angioedema Pregnancy or plans for pregnancy (for semaglutide, discontinue at least two months before planned conception
doi: 10.1177/0748730405277232 63 AkiyamaSOhtaHWatanabeSMoriyaTHariuANakahataNet al
No producen hipoglicemia y ofrecen beneficios adicionales tales como prdida de peso, reduccin de la presin arterial y aumento de HDL
Tracks Medication Doses and Injection Sites Rotating your injection sites properly is crucial to avoid issues like irritation or lipohypertrophy
Users have reported notable results, with some losing up to 10 pounds within a month due to decreased hunger and increased satiety
